Use of COVID-19 convalescent plasma to treat patients
Blood plasma from patients who had recovered from COVID-19, known as COVID-19 convalescent plasma, saved between 16,500 and 66,300 lives, according to a study.
Optimal plasma deployment could have prevented up to an additional 235,000 deaths.